Frank Gupton, CEO of Medicines for All, said he hopes that will lead to production facilities closer to those high need areas like sub-Saharan Africa.

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

Some local officials want to hamper needle exchange programs that public health officials say are crucial to reducing the spread of blood-borne diseases.

Introduction Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy, but its impact is limited by low uptake ...

Compounding that statistic, prior studies indicate some trans people at high risk for HIV transmission are hesitant to take ...

In case you've faced some hurdles solving the clue, HIV-prevention drug, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test ...

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...

Amid steep cuts to U.S. foreign assistance, the Trump administration is touting a new plan to provide a powerful HIV prevention drug to countries most affected by the disease in an ambitious push to ...

This is read by an automated voice. Please report any issues or inconsistencies here. Eswatini becomes the first African country to receive lenacapavir, a twice-yearly HIV prevention injection showing ...